LeMaitre Vascular
LMAT
99 hedge funds and large institutions have $158M invested in LeMaitre Vascular in 2016 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 37 increasing their positions, 34 reducing their positions, and 7 closing their positions.
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
4% more funds holding
Funds holding: 95 → 99 (+4)
9% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 34
4% less capital invested
Capital invested by funds: $164M → $158M (-$6.51M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
Top Sellers
LMAT Hedge Fund Activity: Q2 2016 in Review
99 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q2 2016, worth a combined $158M — down 4% from $164M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new LMAT positions and 7 closed out — a net gain of 5 holders — while 37 added to existing stakes and 34 trimmed.
The largest buyer was Columbia Wanger Asset Management, adding an estimated $7.69M. The largest seller was Driehaus Capital Management, cutting an estimated $2.84M.
- 99 institutional investors held LeMaitre Vascular (LMAT) as of Q2 2016, up from 95 in Q1 2016.
- Funds reported $158M of LeMaitre Vascular stock for Q2 2016, down 4% quarter-over-quarter.
- 12 funds opened new LeMaitre Vascular positions in Q2 2016 and 7 closed out, a net change of +5 holders.
- The largest LeMaitre Vascular buyer in Q2 2016 was Columbia Wanger Asset Management, an estimated $7.69M added.
- The largest LeMaitre Vascular seller in Q2 2016 was Driehaus Capital Management, an estimated $2.84M sold.
Based on aggregated 13F filings for Q2 2016.